©The Author(s) 2023.
World J Gastrointest Surg. Jul 27, 2023; 15(7): 1340-1353
Published online Jul 27, 2023. doi: 10.4240/wjgs.v15.i7.1340
Published online Jul 27, 2023. doi: 10.4240/wjgs.v15.i7.1340
Table 2 Pretransplant treatments, n (%)
| Before PSM | After PSM | |||||
| HCC (n = 141) | cHCC-CC (n = 111) | P value | HCC (n = 70) | cHCC-CC (n = 70) | P value | |
| Locoregional therapy prior to LT | 112 (79.4) | 74 (66.7) | 0.03 | 50 (71.4) | 52 (74.3) | 0.849 |
| TACE | 102 (72.3) | 65 (58.6) | 0.023 | 45 (64.3) | 46 (65.7) | 0.859 |
| Liver resection | 24 (17.0) | 20 (18.0) | 0.868 | 10 (14.3) | 14 (20.0) | 0.502 |
| RFA | 46 (32.6) | 17 (15.3) | 0.002 | 17 (24.3) | 12 (17.1) | 0.404 |
| Radiation therapy | 13 (9.2) | 8 (7.2) | 0.65 | 6 (8.6) | 6 (8.6) | 0.618 |
| Number of locoregional therapies before LT > 3 | 56 (39.7) | 34 (30.6) | 0.147 | 27 (38.6) | 26 (37.1) | 0.862 |
| AFP > 20 ng/mL | 37 (26.2) | 56 (50.5) | < 0.001 | 23 (32.9) | 25 (35.7) | 0.859 |
| PIVKA-II > 40 mAU/mL | 50 (35.5) | 40 (39.2) | 0.591 | 30 (42.9) | 19 (30.2) | 0.152 |
- Citation: Kim J, Joo DJ, Hwang S, Lee JM, Ryu JH, Nah YW, Kim DS, Kim DJ, You YK, Yu HC. Liver transplantation for combined hepatocellular carcinoma and cholangiocarcinoma: A multicenter study. World J Gastrointest Surg 2023; 15(7): 1340-1353
- URL: https://www.wjgnet.com/1948-9366/full/v15/i7/1340.htm
- DOI: https://dx.doi.org/10.4240/wjgs.v15.i7.1340